cbdMD, Inc.
YCBD
$0.86
-$0.05-5.50%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -18.02% | -19.35% | -21.55% | -25.00% | -27.11% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -18.02% | -19.35% | -21.55% | -25.00% | -27.11% |
| Cost of Revenue | -12.93% | -18.43% | -23.83% | -21.80% | -24.67% |
| Gross Profit | -20.90% | -19.91% | -20.17% | -26.79% | -28.43% |
| SG&A Expenses | -28.41% | -28.23% | -29.44% | -28.73% | -38.01% |
| Depreciation & Amortization | -31.80% | -36.15% | -3.69% | -1.89% | -16.94% |
| Other Operating Expenses | -79.67% | -77.78% | -13.57% | -18.97% | -25.16% |
| Total Operating Expenses | -29.60% | -31.79% | -25.67% | -25.26% | -32.97% |
| Operating Income | 67.44% | 64.23% | 37.24% | 26.02% | 46.90% |
| Income Before Tax | 86.54% | 83.87% | 10.47% | 58.00% | 63.59% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 86.54% | 83.87% | 10.47% | 58.00% | 63.59% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 86.54% | 83.87% | 10.47% | 58.00% | 63.59% |
| EBIT | 67.44% | 64.23% | 37.24% | 26.02% | 46.90% |
| EBITDA | 78.56% | 71.00% | 44.09% | 32.83% | 53.04% |
| EPS Basic | 90.67% | 89.92% | -4.85% | 52.09% | 54.02% |
| Normalized Basic EPS | 76.18% | 77.99% | 30.27% | 30.63% | 49.91% |
| EPS Diluted | 90.67% | 89.92% | -4.80% | 52.16% | 54.07% |
| Normalized Diluted EPS | 76.18% | 77.99% | 30.27% | 30.63% | 49.91% |
| Average Basic Shares Outstanding | 129.71% | 164.77% | 63.66% | 73.41% | 44.26% |
| Average Diluted Shares Outstanding | 129.71% | 164.77% | 63.66% | 73.41% | 44.26% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | 0.81% | 0.01% | -0.83% |